论文部分内容阅读
目的评价抗高血压药使用情况。方法采用WHO推荐的限定日剂量法,对本院2009年8月门诊处方抗高血压药的使用情况进行统计。结果钙离子通道颉颃药(CCB)、血管紧张素转化酶抑制剂(ACEI)的使用频率最高。联合用药占全部处方的32.37%,其中两药联用为主,占29.61%。结论本院抗高血压药应用基本符合2005年版《中国高血压防治指南》。单药治疗以第三代钙离子通道颉颃药和血管紧张素Ⅱ受体颉颃药(ARB)为主,新型高选择性β受体阻滞药和ACEI也占重要地位。大部分联合用药方案较合理,但缺乏对联合用药提高血压达标率的认识。处方中存在个别重复用药行为应引起重视。
Objective To evaluate the use of antihypertensive drugs. Methods According to the recommended daily limit of dosage recommended by the WHO, the use of prescription antihypertensive drugs in our hospital in August 2009 was statistically analyzed. Results Calcium channel antagonist (CCB), angiotensin converting enzyme inhibitor (ACEI) the most frequently used. Combined medication accounted for 32.37% of the total prescription, of which the two drugs combined, accounting for 29.61%. Conclusion The application of antihypertensives in our hospital basically conforms to the 2005 edition of “Guidelines for Prevention and Treatment of Hypertension in China”. Monotherapy with the third generation of calcium channel antagonist and angiotensin Ⅱ receptor antagonist drugs (ARB) based, new high selective β-blockers and ACEI also play an important role. Most combination regimens more reasonable, but the lack of joint drug to raise blood pressure compliance rate awareness. The existence of individual repeated medication prescription should pay attention.